BCTXZ vs DHR
BriaCell Therapeutics Corp. Warrant (BCTXZ) versus Danaher Corporation (DHR) — a side-by-side from cached financials, not a winner call.
BriaCell Therapeutics Corp. Warrant (BCTXZ) is a biotechnology company listed on US.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
BCTXZ does not have a complete income-statement cache yet.
Latest reported DHR revenue for 2026-06-26 was $6.26B. Net income was $870.0M. Revenue was up 5.3% from 2026-03-27 to 2026-06-26. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
BCTXZ currently screens at market cap $0. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Not investment advice. Open the BCTXZ and DHR stock pages for the full models.
Not investment advice.